2.03 27% Core EBITDA/t (US$/t)) 107 100 94 14% 97 86 13% Net Operating Debt to Equity 0.84 0.80 0.99 0.84 0.99 Note: (1) Consolidated financials are based upon elimination of intra-company (or intra
EBITDA/t (US$/t)) 122 107 91 34% 105 86 22% Net Operating Debt to Equity 0.57 0.84 0.91 (37)% 0.57 0.91 (37)% Note: (1) Consolidated financials are based upon elimination of intra-company (or intra
3.15 26% Core EBITDA/t (US$/t)) 111 122 90 23% 110 89 24% Net Operating Debt to Equity 0.54 0.57 0.88 (39)% 0.54 0.88 (39)% Note: (1) Consolidated financials are based upon elimination of intra-company
Huntsman assets. 1Consolidated financials are based upon elimination of intra-company or intra-business segment) transactions 2Total of each segment may not always tally with consolidated financials due to
includes Integrated PET, Specialty Chemicals and Packaging. 1Consolidated financials are based upon elimination of intra-company or intra-business segment transactions. 2Total of each segment may not always
16% 0.87 0.71 0.75 16% 1Consolidated financials are based upon elimination of intra-company (or intra-business segment) transactions 2Total of each segment may not always tally with consolidated
107 42% 132 97 36% Operating Cash Flow 240 249 258 (7)% 923 966 (4)% Net Operating Debt to Equity (times) 0.45 0.39 0.84 (46)% 0.45 0.84 (46)% 1Consolidated financials are based upon elimination of
188 61% 1,037 853 21% Net Operating Debt to Equity (times) 0.53 0.45 0.57 (7)% 0.53 0.57 (7)% 1Consolidated financials are based upon elimination of intra-company (or intra-business segment
(3) -103% Elimination (73) (41) 6 108% 115% (228) (134) 41% Profit attributable to owners of the Company 918 1,316 1,386 51% 5% 4,773 5,778 21% Basic earnings per share (Baht) 0.67 0.96 1.01 3.47 4.20